Last reviewed · How we verify
Chemotherapy selected by the physician — Competitive Intelligence Brief
phase 3
Oncology
Small molecule
Live · refreshed every 30 min
Target snapshot
Chemotherapy selected by the physician (Chemotherapy selected by the physician) — Peking Union Medical College Hospital. Physician-selected chemotherapy regimens work by damaging cancer cell DNA or disrupting cell division to inhibit tumor growth.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Chemotherapy selected by the physician TARGET | Chemotherapy selected by the physician | Peking Union Medical College Hospital | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Chemotherapy selected by the physician CI watch — RSS
- Chemotherapy selected by the physician CI watch — Atom
- Chemotherapy selected by the physician CI watch — JSON
- Chemotherapy selected by the physician alone — RSS
Cite this brief
Drug Landscape (2026). Chemotherapy selected by the physician — Competitive Intelligence Brief. https://druglandscape.com/ci/chemotherapy-selected-by-the-physician. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab